What is the immediate treatment for anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Treatment for Anaphylaxis

Intramuscular epinephrine is the only first-line treatment for anaphylaxis and must be administered immediately—all other interventions are secondary and should never delay epinephrine. 1, 2

Primary Intervention: Epinephrine Administration

Administer intramuscular epinephrine 0.01 mg/kg (1:1000 concentration) into the vastus lateralis (anterolateral thigh) immediately upon recognition of anaphylaxis. 1, 3

Dosing specifics:

  • Adults and children >50 kg: 0.5 mg maximum single dose 1
  • Children 25-50 kg: 0.3 mg (or 0.3 mg autoinjector) 1
  • Children 10-25 kg: 0.15 mg (or 0.15 mg autoinjector) 1
  • Repeat every 5-15 minutes if symptoms persist or progress 1

Critical administration details:

  • The lateral thigh (vastus lateralis) is the mandatory injection site because intramuscular administration in the thigh achieves higher peak plasma concentrations more rapidly than subcutaneous or deltoid injection 1
  • There are no absolute contraindications to epinephrine in anaphylaxis, including cardiac disease, advanced age, or frailty 1, 2
  • Epinephrine autoinjectors should be used if available to minimize dosing errors when staff experience is limited 1

Immediate Concurrent Actions

While preparing or immediately after epinephrine:

  • Activate emergency medical services (call 911) 1
  • Position patient supine with legs elevated (if tolerated and no respiratory distress) 1
  • Administer supplemental oxygen at 6-8 L/min 1, 2
  • Establish IV access and give rapid crystalloid bolus: 500-1000 mL in adults, 10-20 mL/kg in children 1, 2

Secondary Adjunctive Treatments (After Epinephrine)

These should never be given before or instead of epinephrine:

For bronchospasm:

  • Inhaled albuterol (2.5-5 mg nebulized) for persistent lower respiratory symptoms after epinephrine 1, 2

Antihistamines (limited role):

  • H1 antihistamine: Diphenhydramine 25-50 mg IV (1-2 mg/kg in children, max 50 mg) 1
  • H2 antihistamine: Ranitidine 50 mg IV over 5 minutes (1 mg/kg in children, diluted in 20 mL) 1, 2
  • Note: The combination of H1 + H2 is superior to H1 alone, but these only address cutaneous manifestations and have no role in life-threatening symptoms 1, 2

Glucocorticoids:

  • Do NOT administer glucocorticoids for acute anaphylaxis treatment due to slow onset of action (hours) 1, 2
  • Do NOT give glucocorticoids to prevent biphasic reactions—multiple systematic reviews show no clear evidence of benefit 1, 2

Repeat Dosing Algorithm

If symptoms persist or progress after initial epinephrine dose:

  • Repeat intramuscular epinephrine every 5-15 minutes as needed 1
  • Approximately 7-18% of patients require >1 dose of epinephrine 1
  • If no response after 2-3 IM doses and patient remains hypotensive, consider IV epinephrine infusion (1:10,000 concentration, NOT 1:1000) in a monitored setting 1, 2

Post-Treatment Observation

All patients must be observed in a monitored setting capable of managing anaphylaxis until symptoms fully resolve: 1

  • Minimum 4-6 hours observation for most patients 1, 2
  • Extended observation (6-24 hours) or hospital admission for severe reactions requiring >1 dose of epinephrine, as these patients have 4.8-fold increased risk of biphasic anaphylaxis 1
  • Biphasic reactions occur in 7-10% of cases, with mean onset at 11 hours (range up to 72 hours) 1

Critical Pitfalls to Avoid

  • Delaying epinephrine administration is the leading cause of anaphylaxis fatalities—approximately 500-1000 deaths occur annually in the US, most from delayed epinephrine 1, 2
  • Never use antihistamines or glucocorticoids as first-line or sole treatment—this significantly increases mortality risk 1, 2, 4
  • Never administer IV epinephrine outside monitored settings or use 1:1000 concentration IV (must use 1:10,000 for IV route) 1, 2
  • Do not give epinephrine subcutaneously or in the deltoid—absorption is significantly slower than IM thigh injection 1

Discharge Requirements

Before discharge, ensure patient receives:

  • Two epinephrine autoinjectors with proper training 1
  • Written anaphylaxis emergency action plan 1
  • Referral to allergist for trigger identification and long-term management 1
  • Education on biphasic reaction risk and when to use autoinjector 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anaphylaxis.

The Journal of emergency medicine, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.